Scienmag
MARCH 14, 2021
. – People who talk with their doctors are more likely to get vaccinated during a pandemic, according to a study of evidence collected during the “swine flu,” the last pandemic to hit the U.S. before COVID-19.
pharmaphorum
MARCH 4, 2022
When it comes to pharma marketing, historically companies have had to either market direct to consumers — and trust them to find a doctor and bring up the company’s product with them — or to send sales reps to doctors — and hope they had the right mix of potential customers among their patients. That number is up 17% from 2019.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
AUGUST 29, 2023
The ABPI UK Pharma Reputation Index is based on an annual programme of opinion research, commissioned by ABPI from Ipsos, that delves into attitudes held by the general public, members of parliament and healthcare professionals (HCPs) regarding the reputation of the UK pharmaceutical industry.
The Pharma Data
AUGUST 14, 2020
Professor Alexander Chuchalin has quit the Russian Health Ministry’s ethics council due to the quick approval process for the country’s coronavirus vaccine. Many countries have criticised Russia pursuit for a COVID-19 cure, which has skipped Phase 3 trials before giving the vaccine regulatory approval. Safety always comes first.
pharmaphorum
FEBRUARY 21, 2022
The clinical research industry has long struggled with participant diversity. A study of FDA-approved vaccine trials from 2011-2020 showed that 78% of participants were white, even though only 60% of the U.S. COVID-19 forced research organisations to adapt. Diversity in COVID-19 vaccine trials. population was. .
The Pharma Data
JUNE 1, 2022
has been appointed Senior Vice President and Head of the Company’s Vaccine Research & Development (R&D) organization effective August 1, succeeding Kathrin U. Anderson most recently served as Vice President and Chief Scientific Officer for Bacterial Research and Hospital within the Vaccine R&D organization.
NY Times
JANUARY 30, 2021
Vaccine development exceeded everyone’s expectations. But the next few months will still bring many sick people — and doctors have woefully few drugs with which to treat them.
Expert insights. Personalized for you.
45 
Let's personalize your content